Exploring differences in the use of the statin choice decision aid and diabetes medication choice decision aid in primary care

Aimee Yu Ballard, Maya Kessler, Marianne Scheitel, Victor Manuel Montori, Rajeev Chaudhry

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Shared decision making is essential to patient centered care, but can be difficult for busy clinicians to implement into practice. Tools have been developed to aid in shared decision making and embedded in electronic medical records (EMRs) to facilitate use. This study was undertaken to explore the patterns of use and barriers and facilitators to use of two decision AIDS, the Statin Choice Decision Aid (SCDA) and the Diabetes Medication Choice Decision Aid (DMCDA), in primary care practices where the decision AIDS are embedded in the EMR. Methods: A survey exploring factors that influenced use of each decision aid was sent to eligible primary care clinicians affiliated with the Mayo Clinic in Rochester, MN. Survey data was collected and clinician use of each decision aid via links from the EMR was tracked. Results: The survey response rate was 40% (105/262). Log file data indicated 51% of clinicians used the SCDA and 9% of clinicians used the DMCDA. Reasons for lack of use included lack of knowledge of the EMR link, not finding the decision AIDS helpful, and time constraints. Survey responses indicated that use of the tool as intended was low, with many clinicians only discussing decision aid topics that they found relevant. Conclusion: Although guidelines for both the treatment of blood cholesterol with a statin and for the treatment of hyperglycemia in type 2 diabetes recommend shared decision making, tools that facilitate shared decision making are not routinely used even when embedded in the EMR. Even when decision AIDS are used, their use may not reflect patient centered care.

Original languageEnglish (US)
Article number118
JournalBMC Medical Informatics and Decision Making
Volume17
Issue number1
DOIs
StatePublished - Oct 8 2017

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Decision Support Techniques
Primary Health Care
Electronic Health Records
Decision Making
Acquired Immunodeficiency Syndrome
Patient-Centered Care
Information Storage and Retrieval
Hyperglycemia
Type 2 Diabetes Mellitus
Cholesterol
Guidelines
Surveys and Questionnaires

ASJC Scopus subject areas

  • Health Policy
  • Health Informatics

Cite this

Exploring differences in the use of the statin choice decision aid and diabetes medication choice decision aid in primary care. / Ballard, Aimee Yu; Kessler, Maya; Scheitel, Marianne; Montori, Victor Manuel; Chaudhry, Rajeev.

In: BMC Medical Informatics and Decision Making, Vol. 17, No. 1, 118, 08.10.2017.

Research output: Contribution to journalArticle

@article{caac4fe47ee241e289c110cc0151a11d,
title = "Exploring differences in the use of the statin choice decision aid and diabetes medication choice decision aid in primary care",
abstract = "Background: Shared decision making is essential to patient centered care, but can be difficult for busy clinicians to implement into practice. Tools have been developed to aid in shared decision making and embedded in electronic medical records (EMRs) to facilitate use. This study was undertaken to explore the patterns of use and barriers and facilitators to use of two decision AIDS, the Statin Choice Decision Aid (SCDA) and the Diabetes Medication Choice Decision Aid (DMCDA), in primary care practices where the decision AIDS are embedded in the EMR. Methods: A survey exploring factors that influenced use of each decision aid was sent to eligible primary care clinicians affiliated with the Mayo Clinic in Rochester, MN. Survey data was collected and clinician use of each decision aid via links from the EMR was tracked. Results: The survey response rate was 40{\%} (105/262). Log file data indicated 51{\%} of clinicians used the SCDA and 9{\%} of clinicians used the DMCDA. Reasons for lack of use included lack of knowledge of the EMR link, not finding the decision AIDS helpful, and time constraints. Survey responses indicated that use of the tool as intended was low, with many clinicians only discussing decision aid topics that they found relevant. Conclusion: Although guidelines for both the treatment of blood cholesterol with a statin and for the treatment of hyperglycemia in type 2 diabetes recommend shared decision making, tools that facilitate shared decision making are not routinely used even when embedded in the EMR. Even when decision AIDS are used, their use may not reflect patient centered care.",
author = "Ballard, {Aimee Yu} and Maya Kessler and Marianne Scheitel and Montori, {Victor Manuel} and Rajeev Chaudhry",
year = "2017",
month = "10",
day = "8",
doi = "10.1186/s12911-017-0514-5",
language = "English (US)",
volume = "17",
journal = "BMC Medical Informatics and Decision Making",
issn = "1472-6947",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Exploring differences in the use of the statin choice decision aid and diabetes medication choice decision aid in primary care

AU - Ballard, Aimee Yu

AU - Kessler, Maya

AU - Scheitel, Marianne

AU - Montori, Victor Manuel

AU - Chaudhry, Rajeev

PY - 2017/10/8

Y1 - 2017/10/8

N2 - Background: Shared decision making is essential to patient centered care, but can be difficult for busy clinicians to implement into practice. Tools have been developed to aid in shared decision making and embedded in electronic medical records (EMRs) to facilitate use. This study was undertaken to explore the patterns of use and barriers and facilitators to use of two decision AIDS, the Statin Choice Decision Aid (SCDA) and the Diabetes Medication Choice Decision Aid (DMCDA), in primary care practices where the decision AIDS are embedded in the EMR. Methods: A survey exploring factors that influenced use of each decision aid was sent to eligible primary care clinicians affiliated with the Mayo Clinic in Rochester, MN. Survey data was collected and clinician use of each decision aid via links from the EMR was tracked. Results: The survey response rate was 40% (105/262). Log file data indicated 51% of clinicians used the SCDA and 9% of clinicians used the DMCDA. Reasons for lack of use included lack of knowledge of the EMR link, not finding the decision AIDS helpful, and time constraints. Survey responses indicated that use of the tool as intended was low, with many clinicians only discussing decision aid topics that they found relevant. Conclusion: Although guidelines for both the treatment of blood cholesterol with a statin and for the treatment of hyperglycemia in type 2 diabetes recommend shared decision making, tools that facilitate shared decision making are not routinely used even when embedded in the EMR. Even when decision AIDS are used, their use may not reflect patient centered care.

AB - Background: Shared decision making is essential to patient centered care, but can be difficult for busy clinicians to implement into practice. Tools have been developed to aid in shared decision making and embedded in electronic medical records (EMRs) to facilitate use. This study was undertaken to explore the patterns of use and barriers and facilitators to use of two decision AIDS, the Statin Choice Decision Aid (SCDA) and the Diabetes Medication Choice Decision Aid (DMCDA), in primary care practices where the decision AIDS are embedded in the EMR. Methods: A survey exploring factors that influenced use of each decision aid was sent to eligible primary care clinicians affiliated with the Mayo Clinic in Rochester, MN. Survey data was collected and clinician use of each decision aid via links from the EMR was tracked. Results: The survey response rate was 40% (105/262). Log file data indicated 51% of clinicians used the SCDA and 9% of clinicians used the DMCDA. Reasons for lack of use included lack of knowledge of the EMR link, not finding the decision AIDS helpful, and time constraints. Survey responses indicated that use of the tool as intended was low, with many clinicians only discussing decision aid topics that they found relevant. Conclusion: Although guidelines for both the treatment of blood cholesterol with a statin and for the treatment of hyperglycemia in type 2 diabetes recommend shared decision making, tools that facilitate shared decision making are not routinely used even when embedded in the EMR. Even when decision AIDS are used, their use may not reflect patient centered care.

UR - http://www.scopus.com/inward/record.url?scp=85027697048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027697048&partnerID=8YFLogxK

U2 - 10.1186/s12911-017-0514-5

DO - 10.1186/s12911-017-0514-5

M3 - Article

VL - 17

JO - BMC Medical Informatics and Decision Making

JF - BMC Medical Informatics and Decision Making

SN - 1472-6947

IS - 1

M1 - 118

ER -